PIK3CA Mutations as a Prognostic Factor in Patients With Residual Rectal Cancer After Neoadjuvant Chemoradiotherapy. Byun J, Park NJ, Yoon G, Kang MK, et al. Anticancer Res 2023;43:1513-1520.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Byun J, Park NJ, Yoon G, Kang MK, et al. PIK3CA Mutations as a Prognostic Factor in Patients With Residual Rectal Cancer After Neoadjuvant Chemoradiotherapy. Anticancer Res 2023;43:1513-1520.
PMID: 36974808